Table 4.

Risk score coefficients by subgroups

SubgroupRisk Score Coefficients (95% CI)
Log (UACR)Serum Creatinine (mg/dl)Serum Albumin (mg/dl)Hemoglobin (g/dl)
All patients1.96 (1.55 to 2.38)1.28 (1.07 to 1.49)−0.78 (−1.09 to −0.48)−0.11 (−0.18 to −0.04)
UACR (g/g)
    <21.29 (0.51 to 2.06)1.47 (1.09 to 1.85)−1.26 (−1.95 to −0.56)−0.20 (−0.32 to −0.08)
    ≥21.90 (0.99 to 2.82)1.18 (0.92 to 1.44)−0.65 (−1.01 to −0.29)−0.05 (−0.13 to 0.03)
Serum creatinine (mg/dl)
    <22.21 (1.55 to 2.86)1.85 (0.97 to 2.74)−0.54 (−1.05 to −0.03)−0.13 (−0.24 to −0.01)
    ≥21.73 (1.19 to 2.27)1.00 (0.61 to 1.38)−0.93 (−1.32 to −0.54)−0.10 (−0.18 to −0.02)
Gender
    male2.09 (1.50 to 2.68)1.12 (0.84 to 1.41)−0.68 (−1.10 to −0.26)−0.10 (−0.20 to −0.01)
    female1.74 (1.14 to 2.33)1.65 (1.28 to 2.02)−0.98 (−1.45 to −0.51)−0.06 (−0.17 to 0.05)
Race
    white1.94 (1.29 to 2.59)1.40 (1.10 to 1.70)−0.83 (−1.33 to −0.33)−0.13 (−0.24 to −0.02)
    nonwhite1.96 (1.41 to 2.51)1.17 (0.86 to 1.48)−0.76 (−1.16 to −0.37)−0.10 (−0.19 to −0.02)
Treatment
    losartan2.07 (1.40 to 2.75)1.27 (0.95 to 1.58)−0.93 (−1.39 to −0.46)−0.13 (−0.24 to −0.03)
    placebo1.93 (1.40 to 2.47)1.33 (1.02 to 1.63)−0.72 (−1.13 to −0.30)−0.09 (−0.17 to −0.01)